Literature DB >> 12664382

[Morganella morganii endophthalmitis after vitrectomy: case report and review of the literature].

Marc Zaninetti1, Edoardo Baglivo, Avinoam B Safran.   

Abstract

BACKGROUND: Postoperative bacterial endophthalmitis are caused in 80 % of the cases by the patient's own flora. Most of the time, bacterial agents are Gram-positive ((2/3) of cases) and more rarely Gram-negative ((1/3) of cases). Usually, Pseudomonas sp, Proteus sp or Klebsiella sp are isolated, but very rarely Morganella morganii. HISTORY AND SIGNS: We describe a case of a Morganella morganii endophthalmitis which occurred after a vitrectomy. THERAPY AND OUTCOME: Bacterial examinations disclosed the presence of Morganella morganii in the vitreous. An aggressive treatment (intravitreous [ceftazidim, vancomycin], topical [gentamycin, chloramphenicol] and intravenous [imipenem, ofloxacin] antibiotics) was introduced. In spite of this treatment, the outcome was not favorable.
CONCLUSIONS: Post-vitrectomy endophthalmitis is very rare and the isolation of a Gram-negative bacteria, in this case Morganella morganii, is infrequent. The outcome of these infections is often poor despite the introduction of a rapid, specific and aggressive treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12664382     DOI: 10.1055/s-2003-38176

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  2 in total

1.  Conjunctival flora of clinically normal and diseased turtles and tortoises.

Authors:  Francesco Di Ianni; Pier Luigi Dodi; Clotilde Silvia Cabassi; Igor Pelizzone; Andrea Sala; Sandro Cavirani; Enrico Parmigiani; Fausto Quintavalla; Simone Taddei
Journal:  BMC Vet Res       Date:  2015-04-10       Impact factor: 2.741

Review 2.  Postvitrectomy endophthalmitis caused by Morganella morganii: a case report and literature review.

Authors:  Chung-Ting Wang; Yin-Hsi Chang; Kuan-Jen Chen; Hung-Da Chou
Journal:  BMC Infect Dis       Date:  2022-03-18       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.